advanced pharmacology Nurs 6521 n week 6 alzheimers disease Mr. Akkad is a 76 year old Iranian male who is brought to your office by his eldest son for “strange behavior.” Mr. Akkad was seen by his family physician who ruled out any organic basis for Mr. Akkad’s behavior. All laboratory and diagnostic imaging tests (including CT-scan of the head) were normal.

Decision Tree for Alzheimer’s Disease For the purposes of this paper, an interactive media piece was chosen to explore a decision tree related to the treatment of Alzheimer’s Disease (AD). The patient presented is a 76- year-old Iranian male, Mr. Akkad, who has been demonstrating strange behavior, forgetfulness, word searching, inappropriate mood, and lack of interest in religious services over the past two years per Mr. Akkad’s son. Based off presenting symptoms a Mini-Mental State Exam (MMSE) was conducted which concluded the diagnosis of major neurocognitive disorder due to Alzheimer’s disease (presumptive). Decision Point 1 Prior to deciding on pharmacotherapy for Mr. Akkad, it is important to identify the severity of his AD. I would categorize his severity as mild based off his forgetfulness, disorientation, and changes in personality. He is still able to recognize his son, have a conversation and displays no unusual motor movements. According to Rosenthal and Burchum (2021) mild severity of AD indicates prescribing a cholinesterase inhibitor. The three medications presented in this decision point are all cholinesterase inhibitors (rivastigmine

Order this paper